Organizing pneumonia following ocrelizumab use in a patient with multiple sclerosis: A case report

dc.authorid0000-0002-5457-9551
dc.authorid0000-0003-4730-2025
dc.authorid0000-0001-6490-447X
dc.authorid0000-0001-5707-2716
dc.contributor.authorAysan, Nurten
dc.contributor.authorKoybasi, Gizem
dc.contributor.authorSatici, Celal
dc.contributor.authorDemirkol, Mustafa Asim
dc.contributor.authorYigitbas, Burcu Arpinar
dc.contributor.authorKosar, Ayse Filiz Arpacag
dc.date.accessioned2025-05-10T19:58:09Z
dc.date.issued2023
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractOrganizing pneumonia following ocrelizumab use in a patient with multiple sclerosis: A case report Ocrelizumab is an anti-CD20 monoclonal antibody used in the treatment of primary progressive and relapsing multiple sclerosis (MS). Although cases of organizing pneumonia have been reported in association with other anti-CD20 agents such as rituximab, there is insufficient data in the literature on Ocrelizumab-associated lung involvement. Herein, we present a case of organizing pneumonia in a 37-year-old female patient with multiple sclerosis following Ocrelizumab use.
dc.identifier.doi10.5578/tt.20239913
dc.identifier.endpage111
dc.identifier.issn0494-1373
dc.identifier.issue1
dc.identifier.pmid36912415
dc.identifier.scopus2-s2.0-85150226174
dc.identifier.scopusqualityQ3
dc.identifier.startpage107
dc.identifier.trdizinid1176825
dc.identifier.urihttps://doi.org/10.5578/tt.20239913
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1176825
dc.identifier.urihttps://hdl.handle.net/20.500.14730/13446
dc.identifier.volume71
dc.identifier.wosWOS:000957606300013
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTurkish Assoc Tuberculosis & Thorax
dc.relation.ispartofTuberkuloz Ve Toraks-Tuberculosis and Thorax
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectOcrelizumab
dc.subjectorganizing pneumonia
dc.subjectdrug induced organizing pneumonia
dc.titleOrganizing pneumonia following ocrelizumab use in a patient with multiple sclerosis: A case report
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
13446.pdf
Boyut:
2.11 MB
Biçim:
Adobe Portable Document Format